Bupivacaine for Benign Headache in the ED

NCT01785459 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped Unable to enroll adequate number of patients.

Conditions

Benign Headache

Interventions

DRUG: 0.5% bupivacaine
DRUG: Standard Care

Sponsor

Wake Forest University Health Sciences